{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T11:35:35.747704+00:00","company":{"ticker":"STEX","cik":1530766,"company_name":"Streamex Corp."},"pagination":{"limit":100,"returned":100,"next_cursor":"2022-11-29T23:59:59+00:00|194092"},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"YA II PN, LTD.","detail":"notes_offering","count":4,"first_seen":"2025-12-19T23:59:59+00:00","last_seen":"2026-02-13T23:59:59+00:00","evidence_fact_ids":[32417,34466,116390,116391]},{"display_name":"Ascendiant Capital Markets, LLC","detail":"atm_program","count":2,"first_seen":"2023-09-15T23:59:59+00:00","last_seen":"2023-11-02T23:59:59+00:00","evidence_fact_ids":[99567,113136]},{"display_name":"Cantor Fitzgerald & Co.","detail":"atm_program","count":2,"first_seen":"2023-08-18T23:59:59+00:00","last_seen":"2023-09-15T23:59:59+00:00","evidence_fact_ids":[113137,118055]},{"display_name":"Needham & Company, LLC","detail":"underwriting","count":1,"first_seen":"2026-01-27T23:59:59+00:00","last_seen":"2026-01-27T23:59:59+00:00","evidence_fact_ids":[34465]},{"display_name":"Terra Capital Natural Resources Fund Pty Ltd.","detail":"equity_purchase","count":1,"first_seen":"2025-12-16T23:59:59+00:00","last_seen":"2025-12-16T23:59:59+00:00","evidence_fact_ids":[122495]},{"display_name":"Virtu Americas LLC","detail":"atm_program","count":1,"first_seen":"2022-11-30T23:59:59+00:00","last_seen":"2022-11-30T23:59:59+00:00","evidence_fact_ids":[193915]}],"lender":[{"display_name":"YA II PN, LTD.","detail":"convertible_notes","count":2,"first_seen":"2025-11-06T23:59:59+00:00","last_seen":"2025-12-19T23:59:59+00:00","evidence_fact_ids":[36412,38453]}]},"facts":[{"fact_type":"executive_change","fact_key":"4c3d998077","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2026-05-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-04-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Mitchell Young Williams was appointed as Director at Streamex Corp..","evidence_excerpt":"On April 28, 2026, the board of directors (the “Board”) of Streamex Corp. (the “Company”) appointed Mr. Mitchell Young Williams, the Company’s Chief Investment Officer, to serve as a non-independent director of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-021131","anchor_url":"https://secwatch.observer/filing/0001493152-26-021131#claim-4c3d998077","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315226021131/0001493152-26-021131-index.htm"},{"fact_type":"material_agreement","fact_key":"5eb2a364ac4385c4058a634decf90926d67e98f5","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2026-02-13T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Yorkville Debentures","agreement_type":"notes_offering","counterparty":"YA II PN, LTD.","effective_date":"2026-02-06","item_codes_triggered":["1.02"],"value_text":"aggregate cash payoff amount of $38,902,740"},"claim":"Streamex Corp. terminated Yorkville Debentures with YA II PN, LTD. valued at aggregate cash payoff amount of $38,902,740 (effective 2026-02-06).","evidence_excerpt":"the Company pre-paid the remaining amounts due under the Yorkville Debentures for an aggregate cash payoff amount of $38,902,740","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-006775","anchor_url":"https://secwatch.observer/filing/0001493152-26-006775#claim-5eb2a364ac4385c4058a634decf90926d67e98f5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315226006775/0001493152-26-006775-index.htm"},{"fact_type":"material_agreement","fact_key":"c177b12d0b184074348f75e39e5f35bbaa24f766","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2026-01-27T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Standby Equity Purchase Agreement","agreement_type":"equity_purchase","counterparty":"YA II PN, Ltd. (Yorkville)","effective_date":"2026-01-22","item_codes_triggered":["1.02"],"value_text":null},"claim":"Streamex Corp. terminated Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville) (effective 2026-01-22).","evidence_excerpt":"On January 22, 2026, Streamex Corp. delivered a notice terminating the Standby Equity Purchase Agreement (the “SEPA”), dated July 7, 2025, with YA II PN, Ltd. (“Yorkville”), effective five trading days after the notice date.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-003818","anchor_url":"https://secwatch.observer/filing/0001493152-26-003818#claim-c177b12d0b184074348f75e39e5f35bbaa24f766","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315226003818/0001493152-26-003818-index.htm"},{"fact_type":"material_agreement","fact_key":"44f546d734ff6b57289d010c1fbec170cf9b6543","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2026-01-27T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Underwriting Agreement","agreement_type":"underwriting","counterparty":"Needham & Company, LLC","effective_date":"2026-01-22","item_codes_triggered":["1.01"],"value_text":null},"claim":"Streamex Corp. entered into Underwriting Agreement with Needham & Company, LLC (effective 2026-01-22).","evidence_excerpt":"On January 22, 2026, Streamex Corp. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Needham & Company, LLC, as representative of the several underwriters (the “Underwriters”), pursuant to which the Company agreed to sell and issue to the Underwriters an aggregate of 11,666,667 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) in a public offering (the “Offering”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-003820","anchor_url":"https://secwatch.observer/filing/0001493152-26-003820#claim-44f546d734ff6b57289d010c1fbec170cf9b6543","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315226003820/0001493152-26-003820-index.htm"},{"fact_type":"material_agreement","fact_key":"45bf084e53d19bb5321d35237218248e2a0f9761","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-12-19T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Second Convertible Debenture (second tranche)","agreement_type":"notes_offering","counterparty":"YA II PN, LTD.","effective_date":"2025-12-17","item_codes_triggered":["1.01"],"value_text":"Issuance of second tranche convertible debenture with principal amount of $25,000,000; conversion pr"},"claim":"Streamex Corp. entered into Second Convertible Debenture (second tranche) with YA II PN, LTD. valued at Issuance of second tranche convertible debenture with principal amount of $25,000,000; conversion pr (effective 2025-12-17).","evidence_excerpt":"greement with YA II PN, LTD., a Cayman Islands exempt limited company (“Yorkville” or the “Investor”), for the\nissuance and sale by the Company of convertible debentures (the “Convertible Debentures,” each, a “Convertible Debenture”), which Convertible Debentures will be convertible into shares of the","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-028606","anchor_url":"https://secwatch.observer/filing/0001493152-25-028606#claim-45bf084e53d19bb5321d35237218248e2a0f9761","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225028606/0001493152-25-028606-index.htm"},{"fact_type":"material_agreement","fact_key":"c56f45102cd185cbd68a1d28db861ea728065663","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-12-19T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Secured Convertible Debenture Purchase Agreement Amendment No. 4","agreement_type":"notes_offering","counterparty":"YA II PN, LTD.","effective_date":"2025-12-17","item_codes_triggered":["1.01"],"value_text":"Amendment to Secured Convertible Debenture Purchase Agreement; $25,000,000 second tranche convertibl"},"claim":"Streamex Corp. amended Secured Convertible Debenture Purchase Agreement Amendment No. 4 with YA II PN, LTD. valued at Amendment to Secured Convertible Debenture Purchase Agreement; $25,000,000 second tranche convertibl (effective 2025-12-17).","evidence_excerpt":"Further to this, on December 17, 2025, the Company entered into a certain Amendment No. 4 to the Debenture Purchase Agreement (the “Fourth Amendment”) with Yorkville.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-028606","anchor_url":"https://secwatch.observer/filing/0001493152-25-028606#claim-c56f45102cd185cbd68a1d28db861ea728065663","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225028606/0001493152-25-028606-index.htm"},{"fact_type":"equity_issuance","fact_key":"010d8f089c6c152e344b3b7ebd10bd055c69c12d","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-12-19T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"principal amount of $25,000,000","effective_date":"2025-12-17","item_codes_triggered":["3.02"],"purchaser":"YA II PN, LTD. (Yorkville)","security_type":"convertible_note","shares_text":null},"claim":"Streamex Corp. issued convertible note to YA II PN, LTD. (Yorkville) for principal amount of $25,000,000.","evidence_excerpt":"on December 17, 2025 (the \"Second Closing Date\"), the Company issued the second tranche of Convertible Debenture to Yorkville with a principal amount of $25,000,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-028606","anchor_url":"https://secwatch.observer/filing/0001493152-25-028606#claim-010d8f089c6c152e344b3b7ebd10bd055c69c12d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225028606/0001493152-25-028606-index.htm"},{"fact_type":"debt_financing","fact_key":"4967409b888509b31db6a9e67b76b4740f5a66da","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-12-19T23:59:59+00:00","payload":{"counterparty":"YA II PN, LTD.","effective_date":"2025-12-17","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"4.00% per annum, which will increase to 18.00% per annum upon the occurrence of","item_codes_triggered":["2.03"],"maturity_text":"December 17, 2027","principal_text":"$25,000,000"},"claim":"Streamex Corp. incurred convertible notes of $25,000,000 with YA II PN, LTD. at 4.00% per annum, which will increase to 18.00% per annum upon the occurrence of maturing December 17, 2027.","evidence_excerpt":"on December 17, 2025 (the “Second Closing Date”), the Company issued the second tranche of Convertible Debenture to Yorkville with a principal amount of $25,000,000 (the “Second Convertible Debenture”), on similar terms as the initial tranche of Convertible Debenture to Yorkville, dated November 4, 2025, as disclosed in our Prior Form 8-Ks.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-028606","anchor_url":"https://secwatch.observer/filing/0001493152-25-028606#claim-4967409b888509b31db6a9e67b76b4740f5a66da","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225028606/0001493152-25-028606-index.htm"},{"fact_type":"material_agreement","fact_key":"357d4118dcefa04c7006186252f5265ee86809a3","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-12-16T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Share Purchase Agreement","agreement_type":"equity_purchase","counterparty":"Terra Capital Natural Resources Fund Pty Ltd.","effective_date":"2025-12-11","item_codes_triggered":["1.01"],"value_text":"US$12,218,751.00"},"claim":"Streamex Corp. entered into Share Purchase Agreement with Terra Capital Natural Resources Fund Pty Ltd. valued at US$12,218,751.00 (effective 2025-12-11).","evidence_excerpt":"On December 11, 2025, Streamex Corp. (the “Company”) entered into a Share Purchase Agreement (the “Purchase Agreement”) with Terra Capital Natural Resources Fund Pty Ltd. (“Purchaser”) pursuant to which the Company acquired a 9.9% equity interest in Empress Royalty Corp.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-027987","anchor_url":"https://secwatch.observer/filing/0001493152-25-027987#claim-357d4118dcefa04c7006186252f5265ee86809a3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225027987/0001493152-25-027987-index.htm"},{"fact_type":"equity_issuance","fact_key":"d06ecd737ed6d9661e702c11436f7ee298392bb1","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-12-16T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"12,671,297 shares of Empress common stock","effective_date":null,"item_codes_triggered":["3.02"],"purchaser":"Terra Capital Natural Resources Fund Pty Ltd.","security_type":"common_stock","shares_text":"2,443,750 shares of Common Stock"},"claim":"Streamex Corp. issued 2,443,750 shares of Common Stock of common stock to Terra Capital Natural Resources Fund Pty Ltd. for 12,671,297 shares of Empress common stock.","evidence_excerpt":"the Company issued 2,443,750 shares of Common Stock to Purchaser in exchange for 12,671,297 shares of Empress common stock held by Purchaser.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-027987","anchor_url":"https://secwatch.observer/filing/0001493152-25-027987#claim-d06ecd737ed6d9661e702c11436f7ee298392bb1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225027987/0001493152-25-027987-index.htm"},{"fact_type":"governance_change","fact_key":"9bc0908e4ac04bf9642f65ed930975d90d5c211f","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-11-19T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-11-19","item_codes_triggered":["5.03"],"summary_text":"Company filed the Eleventh Amendment to its Amended and Restated Certificate of Incorporation to provide for a classified Board divided into three classes."},"claim":"Streamex Corp.: Company filed the Eleventh Amendment to its Amended and Restated Certificate of Incorporation to provide for a classified Board divided into three classes (effective 2025-11-19).","evidence_excerpt":"On November 19, 2025 (the “Effective Date”) , the Company filed the Eleventh Amendment (the “Charter Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State, which became effective upon filing . The Charter Amendment provides for a classified Board, with the Board divided into three classes, pursuant to prior authorization of the Board and the requisite stockholders of the Company as more fully described in the Company’s definitive proxy statement filed with the SEC on August 4, 2025, as amended on August 15, 2025, September 2, 2025 and September 3, 2025 and the Company’s Current Report on Form 8-K filed with the SEC on September 5, 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-024294","anchor_url":"https://secwatch.observer/filing/0001493152-25-024294#claim-9bc0908e4ac04bf9642f65ed930975d90d5c211f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225024294/0001493152-25-024294-index.htm"},{"fact_type":"equity_issuance","fact_key":"fc50cadff9e5958136a757155a698383d9b3413a","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-11-06T23:59:59+00:00","payload":{"action":"pipe","consideration_text":"$25,000,000 principal amount","effective_date":"2025-11-04","item_codes_triggered":["3.02"],"purchaser":"YA II PN, LTD.","security_type":"convertible_note","shares_text":null},"claim":"Streamex Corp. issued convertible note to YA II PN, LTD. for $25,000,000 principal amount.","evidence_excerpt":"the Company issued an initial tranche of Convertible Debenture to Yorkville with a principal amount of $25,000,000 (the \"First Convertible Debenture\").","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-021102","anchor_url":"https://secwatch.observer/filing/0001493152-25-021102#claim-fc50cadff9e5958136a757155a698383d9b3413a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225021102/0001493152-25-021102-index.htm"},{"fact_type":"debt_financing","fact_key":"11034613745ce4667db31a71a40bcb6e20fcc178","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-11-06T23:59:59+00:00","payload":{"counterparty":"YA II PN, LTD.","effective_date":"2025-11-04","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"4.00% per annum, increasing to 18.00% per annum upon an event of default","item_codes_triggered":["2.03"],"maturity_text":"November 4, 2027","principal_text":"$25,000,000"},"claim":"Streamex Corp. incurred convertible notes of $25,000,000 with YA II PN, LTD. at 4.00% per annum, increasing to 18.00% per annum upon an event of default maturing November 4, 2027.","evidence_excerpt":"Further to this, on November 4, 2025 (the “First Closing Date”), the Company issued an initial tranche of Convertible Debenture to Yorkville with a principal amount of $25,000,000 (the “First Convertible Debenture”). The First Convertible Debenture will mature on November 4, 2027, and will accrue interest at the rate of 4.00% per annum, which will increase to 18.00% per annum upon the occurrence of an event of default, until such event of default is cured.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-021102","anchor_url":"https://secwatch.observer/filing/0001493152-25-021102#claim-11034613745ce4667db31a71a40bcb6e20fcc178","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225021102/0001493152-25-021102-index.htm"},{"fact_type":"equity_issuance","fact_key":"8af61e8a06f07656284a5681371682ef28c12a36","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-10-29T23:59:59+00:00","payload":{"action":"private_placement","consideration_text":"$25,000,000 principal amount","effective_date":null,"item_codes_triggered":["3.02"],"purchaser":"YA II PN, LTD.","security_type":"convertible_note","shares_text":null},"claim":"Streamex Corp. issued convertible note to YA II PN, LTD. for $25,000,000 principal amount.","evidence_excerpt":"the Company will issue to Yorkville a Convertible Debenture in the principal amount of $25,000,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-25-019993","anchor_url":"https://secwatch.observer/filing/0001493152-25-019993#claim-8af61e8a06f07656284a5681371682ef28c12a36","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225019993/0001493152-25-019993-index.htm"},{"fact_type":"governance_change","fact_key":"dc2ade5897ca1aafccf4511961d86b04f5f10a81","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-09-11T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-09-10","item_codes_triggered":["5.03"],"summary_text":"Amended certificate of incorporation to change company name from BioSig Technologies, Inc. to Streamex Corp."},"claim":"Streamex Corp.: Amended certificate of incorporation to change company name from BioSig Technologies, Inc. to Streamex Corp (effective 2025-09-10).","evidence_excerpt":"On September 10, 2025, BioSig Technologies, Inc. (the “Company”) filed an amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to effect a change in the name of the Company from “BioSig Technologies, Inc.” to “Streamex Corp.” (the “Name Change”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-027127","anchor_url":"https://secwatch.observer/filing/0001641172-25-027127#claim-dc2ade5897ca1aafccf4511961d86b04f5f10a81","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225027127/0001641172-25-027127-index.htm"},{"fact_type":"governance_change","fact_key":"bfb2d73650c2b43d93bbf2b6ad289356d69c69d2","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-09-05T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-09-05","item_codes_triggered":["5.03"],"summary_text":"Approved and filed the Ninth Certificate of Amendment to increase authorized common shares from 200,000,000 to 500,000,000"},"claim":"Streamex Corp.: Approved and filed the Ninth Certificate of Amendment to increase authorized common shares from 200,000,000 to 500,000,000 (effective 2025-09-05).","evidence_excerpt":"The Company filed the Ninth Certificate of Amendment, which was effective upon filing, with the Secretary of State of the State of Delaware on September 5, 2025.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-026749","anchor_url":"https://secwatch.observer/filing/0001641172-25-026749#claim-bfb2d73650c2b43d93bbf2b6ad289356d69c69d2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225026749/0001641172-25-026749-index.htm"},{"fact_type":"governance_change","fact_key":"8fd9e093c82b1d1a3186e1269828c3e35d10efeb","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-05-28","item_codes_triggered":["5.03"],"summary_text":"Filed Special Voting Certificate of Designation with the Delaware Secretary of State to establish Special Voting Preferred Stock"},"claim":"Streamex Corp.: Filed Special Voting Certificate of Designation with the Delaware Secretary of State to establish Special Voting Preferred Stock (effective 2025-05-28).","evidence_excerpt":"On and effective May 28, 2025, the Company filed the Special Voting Certificate of Designation with the Secretary of State of the State of Delaware to establish the Special Voting Preferred Stock.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-8fd9e093c82b1d1a3186e1269828c3e35d10efeb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"executive_change","fact_key":"f2d0e32f78","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-05-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Frederick D. Hrkac resigned as Director at Streamex Corp..","evidence_excerpt":"Frederick D. Hrkac resigned from the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-f2d0e32f78","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"executive_change","fact_key":"44d446040b","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Morgan Lekstrom was appointed as Director at Streamex Corp..","evidence_excerpt":"Mr. McPhie and Mr. Lekstrom were appointed as new directors of the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-44d446040b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"executive_change","fact_key":"175479582c","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-28","interim":false,"role":"Chairman of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Morgan Lekstrom was appointed as Chairman of the Board at Streamex Corp..","evidence_excerpt":"Morgan Lekstrom, co-founder and Chairman of Streamex, was appointed as the Chairman of the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-175479582c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"executive_change","fact_key":"1275fa3ba2","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Henry McPhie was appointed as Director at Streamex Corp..","evidence_excerpt":"Mr. McPhie and Mr. Lekstrom were appointed as new directors of the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-1275fa3ba2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"executive_change","fact_key":"a1794fe1e4","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-28","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Henry McPhie was appointed as Chief Executive Officer at Streamex Corp..","evidence_excerpt":"Henry McPhie, co-founder and Chief Executive Officer of Streamex, was appointed the Company’s new Chief Executive Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-a1794fe1e4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"executive_change","fact_key":"e5a8712ab1","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-05-28","interim":false,"role":"Chief Executive Officer, President and Chairman of the Board","role_category":"ceo","successor_name":"Henry McPhie","successor_named":true},"claim":"Anthony Amato resigned as Chief Executive Officer, President and Chairman of the Board at Streamex Corp..","evidence_excerpt":"Anthony Amato, the Company’s Chief Executive Officer, President and Chairman of the Board of Directors of the Company (the “Board”), resigned as Chief Executive Officer, President and Chairman of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001641172-25-013022","anchor_url":"https://secwatch.observer/filing/0001641172-25-013022#claim-e5a8712ab1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013022/0001641172-25-013022-index.htm"},{"fact_type":"governance_change","fact_key":"7d4149fd663d849e6761db0b9618b67533bd7599","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-27T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Company agrees to file Special Voting Certificate of Designation to establish Special Voting Preferred Stock."},"claim":"Streamex Corp.: Company agrees to file Special Voting Certificate of Designation to establish Special Voting Preferred Stock.","evidence_excerpt":"Pursuant to the Share Purchase Agreement, the Company has agreed to file the Special Voting Certificate of Designation with the Secretary of State of the State of Delaware to establish the Special Voting Preferred Stock.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001641172-25-012363","anchor_url":"https://secwatch.observer/filing/0001641172-25-012363#claim-7d4149fd663d849e6761db0b9618b67533bd7599","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225012363/0001641172-25-012363-index.htm"},{"fact_type":"executive_change","fact_key":"9ed2d48ec0","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-05-27T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":null,"interim":false,"role":null,"role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Anthony Amato resigned as other_named_officer at Streamex Corp..","evidence_excerpt":"In connection with Mr. Amato’s resignation pursuant to the Share Purchase Agreement, the Company and Mr. Amato expect to enter into (i) a First Amendment to the Executive Employment Agreement (the “First Amendment”) and (ii) a letter agreement (the “Right to Place”).","confidence":0.75,"filing_url":"https://secwatch.observer/filing/0001641172-25-012363","anchor_url":"https://secwatch.observer/filing/0001641172-25-012363#claim-9ed2d48ec0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225012363/0001641172-25-012363-index.htm"},{"fact_type":"auditor_change","fact_key":"1d6958ad297bf215c10b1aca7610bb9733e21d0c","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-04-30T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"CBIZ CPAs P.C.","disagreement_text":"During period through April 30, 2025, there were no disagreements with Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s), if not resolved to the satisfaction of Marcum, would have caused it to make reference to the subject matter of the disagreement(s) in connection with its report.","effective_date":"2025-04-30","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Streamex Corp. engaged CBIZ CPAs P.C. as its auditor.","evidence_excerpt":"Also on April 30, 2025, the Registrant, with the approval of the Audit Committee of the Registrant’s Board of Directors, engaged CBIZ CPAs P.C. as the Registrant’s independent registered public accounting firm.","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001641172-25-007596","anchor_url":"https://secwatch.observer/filing/0001641172-25-007596#claim-1d6958ad297bf215c10b1aca7610bb9733e21d0c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225007596/0001641172-25-007596-index.htm"},{"fact_type":"auditor_change","fact_key":"aacb5173f1588635298422e34b8024a47bf25775","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-04-30T23:59:59+00:00","payload":{"action":"resignation","auditor_name":"Marcum LLP","disagreement_text":"During period through April 30, 2025, there were no disagreements with Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s), if not resolved to the satisfaction of Marcum, would have caused it to make reference to the subject matter of the disagreement(s) in connection with its report.","effective_date":"2025-04-30","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Marcum LLP resigned as auditor of Streamex Corp..","evidence_excerpt":"On April 30, 2025, Marcum informed BioSig Technologies, Inc. (the “Registrant”) that Marcum resigned as the Registrant’s independent registered public accounting firm.","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001641172-25-007596","anchor_url":"https://secwatch.observer/filing/0001641172-25-007596#claim-aacb5173f1588635298422e34b8024a47bf25775","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225007596/0001641172-25-007596-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"b6c4341571846cbcc47939520bbcb35777c15e76","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2025-04-15T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-04-11","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"April 11, 2025, BioSig Technologies,\nInc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”)\nindicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period\nbetween February 27, 2025, through April 10, 2025, the Company did not meet the minimum bid price of $1.00 per share required for continued\nlisting on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided\nwith a compliance period of 180 calenda","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001641172-25-004850","anchor_url":"https://secwatch.observer/filing/0001641172-25-004850#claim-b6c4341571846cbcc47939520bbcb35777c15e76","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225004850/0001641172-25-004850-index.htm"},{"fact_type":"executive_change","fact_key":"148e926711","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-09-13T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-11","interim":false,"role":"Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Anthony Amato was appointed as Chairman at Streamex Corp..","evidence_excerpt":"On September 11, 2024, pursuant to Section 5.2 of the Company’s bylaws, the Board appointed the Company’s chief executive officer, Mr. Anthony Amato, as Chairman.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-036190","anchor_url":"https://secwatch.observer/filing/0001493152-24-036190#claim-148e926711","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224036190/0001493152-24-036190-index.htm"},{"fact_type":"executive_change","fact_key":"a757b4bb9b","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-09-13T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-27","interim":false,"role":"Chairman","role_category":"chair","successor_name":"Anthony Amato","successor_named":true},"claim":"Kenneth L. Londoner resigned as Chairman at Streamex Corp..","evidence_excerpt":"As previously announced on February 27, 2024, Kenneth L. Londoner, the former chairperson (“Chairman”) of the Board of Directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) resigned from the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-036190","anchor_url":"https://secwatch.observer/filing/0001493152-24-036190#claim-a757b4bb9b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224036190/0001493152-24-036190-index.htm"},{"fact_type":"executive_change","fact_key":"9fc2187fc4","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-06-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-05","interim":true,"role":"interim chief financial officer, principal accounting officer and vice president of finance","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Ferdinand Groenewald was appointed as interim chief financial officer, principal accounting officer and vice president of finance at Streamex Corp..","evidence_excerpt":"Mr. Groenewald will serve as the Company’s interim chief financial officer, principal accounting officer and vice president of finance.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-023293","anchor_url":"https://secwatch.observer/filing/0001493152-24-023293#claim-9fc2187fc4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm"},{"fact_type":"executive_change","fact_key":"5fe4ef9550","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-06-10T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-06-05","interim":true,"role":"acting chief financial officer and principal accounting officer","role_category":"cfo","successor_name":"Ferdinand Groenewald","successor_named":true},"claim":"Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer at Streamex Corp..","evidence_excerpt":"On June 5, 2024, Mr. Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer of BioSig Technologies, Inc. (“BioSig” or “Company”) effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-023293","anchor_url":"https://secwatch.observer/filing/0001493152-24-023293#claim-5fe4ef9550","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"458a1987c1cd3fc902eb67288604d40e3d2b2fe1","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2024-03-05","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":"market value of listed securities, public shell, and independent board and board committee requirements (specific rule identifiers not provided)","reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)(2)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq noncompliance notice notice regarding other (rules 5550(a)(2), 5810(c)(3)(A)(2)).","evidence_excerpt":"March 5, 2024, stating that the Company has not regained compliance with Listing Rule\n5550(a)(2) because the Company’s common stock did not meet the minimum bid price of $1.00 per share required for continued listing\non The Nasdaq Capital Market, and the Company is not eligible for a second 180 day cure period under Rule 5810(c)(3)(A)(2) because the\nCompany does not comply with the $5,000,000 minimum stockholders’ equity initial listing requirement for The Nasdaq Capital Market,\nand that accordingly, Nasdaq would delist the Company’s common stock unless the Company requested an appeal of this","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0001493152-24-018060","anchor_url":"https://secwatch.observer/filing/0001493152-24-018060#claim-458a1987c1cd3fc902eb67288604d40e3d2b2fe1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224018060/0001493152-24-018060-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"0a2385e7c2d0d3cd712b967229f58b9152738122","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"regained_compliance","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$1.00 per share","notice_date":"2024-05-06","notice_type":"compliance_regained","plan_due_date":null,"raw_rule_text":"bid price requirements in Listing Rule 5550(a)(2)","reported_value":"bid price closed at or above $1.00 for 20 consecutive days (Apr 8 to May 3, 2024)","rule_numbers":["5550(a)(2)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"May 6, 2024, the Company received a letter from the Staff stating that the Company has regained compliance with the bid price requirements\nin Listing Rule 5550(a)(2) because the bid price of the common stock closed at or above $1.00 per share for a period of 20 consecutive\nbusiness days, from April 8, 2024 to May 3, 2024. The\nCompany remains, however, non-compliant with The Nasdaq Stock Market’s market value of listed securities, public shell, and independent\nboard and board committee requirements. Therefore, the May 7, 2024, hearing will be held as scheduled. SIGNATURES Pursuant\nto the requir","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-018060","anchor_url":"https://secwatch.observer/filing/0001493152-24-018060#claim-0a2385e7c2d0d3cd712b967229f58b9152738122","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224018060/0001493152-24-018060-index.htm"},{"fact_type":"executive_change","fact_key":"e3ea1784b9","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-02","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Chris Baer was appointed as Director at Streamex Corp..","evidence_excerpt":"As previously announced on May 2, 2024, the Board appointed Mr. Chris Baer as a director on the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-017958","anchor_url":"https://secwatch.observer/filing/0001493152-24-017958#claim-e3ea1784b9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224017958/0001493152-24-017958-index.htm"},{"fact_type":"executive_change","fact_key":"b1b747df73","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-03","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Donald F. Browne was appointed as Director at Streamex Corp..","evidence_excerpt":"On May 3, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Messrs. Steven E. Abelman and Donald F. Browne as directors on the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-017958","anchor_url":"https://secwatch.observer/filing/0001493152-24-017958#claim-b1b747df73","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224017958/0001493152-24-017958-index.htm"},{"fact_type":"executive_change","fact_key":"19a0fad8cd","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-03","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Steven E. Abelman was appointed as Director at Streamex Corp..","evidence_excerpt":"On May 3, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Messrs. Steven E. Abelman and Donald F. Browne as directors on the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-017958","anchor_url":"https://secwatch.observer/filing/0001493152-24-017958#claim-19a0fad8cd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224017958/0001493152-24-017958-index.htm"},{"fact_type":"executive_change","fact_key":"e6d352bef7","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-03T23:59:59+00:00","payload":{"action":"resigned","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-04-30","interim":true,"role":"Director and Acting Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Mr. Hrkac resigned as Director and Acting Chief Financial Officer at Streamex Corp..","evidence_excerpt":"In connection with the appointment of Mr. Amato, Mr. Hrkac tendered his resignation as president and principal executive officer effective as of the same date, however, will continue to serve as a director and acting chief financial officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-017634","anchor_url":"https://secwatch.observer/filing/0001493152-24-017634#claim-e6d352bef7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224017634/0001493152-24-017634-index.htm"},{"fact_type":"executive_change","fact_key":"e45440a484","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-03T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-04-30","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Anthony Amato was appointed as Chief Executive Officer at Streamex Corp..","evidence_excerpt":"On April 30, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed former advisory board member and consultant, Anthony Amato as a director, president, chief executive officer and principal executive officer, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-017634","anchor_url":"https://secwatch.observer/filing/0001493152-24-017634#claim-e45440a484","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224017634/0001493152-24-017634-index.htm"},{"fact_type":"executive_change","fact_key":"db7b7cbfb2","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-05-02T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-05-02","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Chris Baer was appointed as director at Streamex Corp..","evidence_excerpt":"On May 2, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Mr. Chris Baer as a director on the Board.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-017546","anchor_url":"https://secwatch.observer/filing/0001493152-24-017546#claim-db7b7cbfb2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224017546/0001493152-24-017546-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"438b23c7d6a49e66c8e07fef4b0cd48debdc09e3","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-03-18T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"delisting_pending","cure_deadline":null,"deficiency_type":"board_independence","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2024-03-12","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":"Listing Rule 5101; Listing Rule 5605","reported_value":null,"rule_numbers":["5101","5605"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq delisting notice notice regarding board independence (rules 5101, 5605).","evidence_excerpt":"March 12, 2024, the Company received a letter from the Staff stating that based upon the Staff’s review of the Company and pursuant\nto Listing Rule 5101, the Staff believes that the Company no longer has an operating business and is a “public shell,” and\nthat the continued listing of its securities is no longer warranted, in view of the following: ● On\n February 5, 2024, the Company disclosed in a Form 8-K that the Company commenced a workforce reduction consisting of 16 employees\n including the Chief Operating Officer and the Chief Commercial Officer; ● On\n February 21, 2024, the Company disc","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-010175","anchor_url":"https://secwatch.observer/filing/0001493152-24-010175#claim-438b23c7d6a49e66c8e07fef4b0cd48debdc09e3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/0001493152-24-010175-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"28a96030ddc197ababf1f8a768c48399c25fe4ac","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-03-18T23:59:59+00:00","payload":{"company_response":"hearing requested on March 11, 2024","compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2024-03-05","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":"Listing Rule 5550(a)(2); Rule 5810(c)(3)(A)(2)","reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)(2)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(2)).","evidence_excerpt":"March 5, 2024, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications\nDepartment of Nasdaq (the “Staff”) stating that the Company has not regained compliance with Listing Rule 5550(a)(2) because\nthe Company’s common stock did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital\nMarket, and the Company is not eligible for a second 180 day cure period under Rule 5810(c)(3)(A)(2) because the Company does not comply\nwith the $5,000,000 minimum stockholders’ equity initial listing requirement for The Nasdaq Capit","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-010175","anchor_url":"https://secwatch.observer/filing/0001493152-24-010175#claim-28a96030ddc197ababf1f8a768c48399c25fe4ac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/0001493152-24-010175-index.htm"},{"fact_type":"material_agreement","fact_key":"76df0648467094d2b772a6dd4f91414718be3185","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-03-12T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Promissory Note","agreement_type":"notes_offering","counterparty":"an investor","effective_date":"2024-03-07","item_codes_triggered":["1.01"],"value_text":"$500,000"},"claim":"Streamex Corp. entered into Promissory Note with an investor valued at $500,000 (effective 2024-03-07).","evidence_excerpt":"On March 7, 2024, BioSig Technologies Inc. (the “Company”) issued a Promissory Note (the “Note”) to an investor for $500,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-009635","anchor_url":"https://secwatch.observer/filing/0001493152-24-009635#claim-76df0648467094d2b772a6dd4f91414718be3185","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224009635/0001493152-24-009635-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"9900b218f64893e4faed51054cbf28ebbb3e9386","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-03-11T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2024-03-05","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)","5810(c)(3)(A)(2)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(2)).","evidence_excerpt":"March 5, 2024, the Company received a letter from the Listing Qualifications Department of Nasdaq stating that the Company has not regained\ncompliance with the Rule and is not eligible for a second 180 day period under Rule 5810(c)(3)(A)(2) because the Company does not comply\nwith the $5,000,000 minimum stockholders’ equity initial listing requirement for The Nasdaq Capital Market, and that accordingly,\nNasdaq would delist the Company’s common stock unless the Company requested an appeal of this determination. On March 11, 2024, the Company submitted a request for a hearing\nbefore the Nasdaq H","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-009494","anchor_url":"https://secwatch.observer/filing/0001493152-24-009494#claim-9900b218f64893e4faed51054cbf28ebbb3e9386","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224009494/0001493152-24-009494-index.htm"},{"fact_type":"executive_change","fact_key":"d7dc830c98","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-28T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-02-27","interim":false,"role":"President and Principal Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Frederick D. Hrkac was appointed as President and Principal Executive Officer at Streamex Corp..","evidence_excerpt":"On February 27, 2024, the Board appointed former director, Frederick D. Hrkac as a director, president and principal executive officer of the Company, effective as of February 27, 2024 (the “Effective Date”), to serve for a term expiring at the next annual meeting of the Company’s stockholders or until his successor is duly elected and qualified, or his earlier death, resignation or removal.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-008052","anchor_url":"https://secwatch.observer/filing/0001493152-24-008052#claim-d7dc830c98","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224008052/0001493152-24-008052-index.htm"},{"fact_type":"executive_change","fact_key":"560f872dcd","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-28T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-27","interim":false,"role":"Chief Executive Officer and Executive Chairman","role_category":"ceo","successor_name":"Frederick D. Hrkac","successor_named":true},"claim":"Kenneth L. Londoner resigned as Chief Executive Officer and Executive Chairman at Streamex Corp..","evidence_excerpt":"Kenneth L. Londoner resigned from his positions as director, executive chairman and chief executive officer of BioSig Technologies, Inc. (the “ Company ”) and from any and all committees, offices, appointments, designations, responsibilities or other capacities related to the Company or any of its subsidiaries, effective as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-008052","anchor_url":"https://secwatch.observer/filing/0001493152-24-008052#claim-560f872dcd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224008052/0001493152-24-008052-index.htm"},{"fact_type":"executive_change","fact_key":"01838a40c5","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-20","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Frederick D. Hrkac resigned as director at Streamex Corp..","evidence_excerpt":"On February 20, 2024, James L. Klein and Frederick D. Hrkac resigned from their positions as directors of the Company, effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-01838a40c5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"executive_change","fact_key":"c36551c2d5","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-20","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"James L. Klein resigned as director at Streamex Corp..","evidence_excerpt":"On February 20, 2024, James L. Klein and Frederick D. Hrkac resigned from their positions as directors of the Company, effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-c36551c2d5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"executive_change","fact_key":"2833a47575","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-19","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"James J. Barry resigned as director at Streamex Corp..","evidence_excerpt":"On February 19, 2024, David Weild IV, Donald E. Foley, Patrick J. Gallagher and James J. Barry, resigned from their positions as directors of the Company, effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-2833a47575","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"executive_change","fact_key":"9f6f870621","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-19","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Patrick J. Gallagher resigned as director at Streamex Corp..","evidence_excerpt":"On February 19, 2024, David Weild IV, Donald E. Foley, Patrick J. Gallagher and James J. Barry, resigned from their positions as directors of the Company, effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-9f6f870621","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"executive_change","fact_key":"a9a429c1b1","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-19","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Donald E. Foley resigned as director at Streamex Corp..","evidence_excerpt":"On February 19, 2024, David Weild IV, Donald E. Foley, Patrick J. Gallagher and James J. Barry, resigned from their positions as directors of the Company, effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-a9a429c1b1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"executive_change","fact_key":"7d8c2bb376","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-19","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"David Weild IV resigned as director at Streamex Corp..","evidence_excerpt":"On February 19, 2024, David Weild IV, Donald E. Foley, Patrick J. Gallagher and James J. Barry, resigned from their positions as directors of the Company, effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-7d8c2bb376","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"executive_change","fact_key":"700288a9c9","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-21T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-02-15","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Steve Buhaly resigned as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 15, 2024, Steve Buhaly resigned from his position as the Chief Financial Officer of BioSig Technologies, Inc. (the “ Company ”), effective as of the same date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-007392","anchor_url":"https://secwatch.observer/filing/0001493152-24-007392#claim-700288a9c9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224007392/0001493152-24-007392-index.htm"},{"fact_type":"restructuring_charge","fact_key":"020f39f8df5e4a0253c6760d2a6e12c070615757","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-02T23:59:59+00:00","payload":{"affected_area":null,"charge_text":"approximately $713,924","effective_date":"2024-01-28","event_type":"restructuring","headcount_text":"sixteen employees","item_codes_triggered":["2.05"]},"claim":"Streamex Corp. announced a restructuring with charges of approximately $713,924 (sixteen employees).","evidence_excerpt":"On January 28, 2024, management of the Company commenced a workforce reduction intended to reduce annual cash burn by approximately 50%, which was completed as of January 31, 2024. The workforce reduction consisted of the departure of sixteen employees, effective as of January 31, 2024 (the “Effective Date”) and included the departure of John Sieckhaus, the Company’s Chief Operating Officer, and Gray Fleming, the Company’s Chief Commercial Officer. In connection with the reduction in force, the Company estimates it will incur total aggregate costs of approximately $713,924, which consists of one-time departure fees and severance packages for employees in equity, based on factors including years of employment, in the estimated amount of $135,288 and retention bonuses paid in equity in the estimated amount of $578,636.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-004796","anchor_url":"https://secwatch.observer/filing/0001493152-24-004796#claim-020f39f8df5e4a0253c6760d2a6e12c070615757","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224004796/0001493152-24-004796-index.htm"},{"fact_type":"restructuring_charge","fact_key":"800920b58914657d786a508dc1c2ddf5b1268912","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-01T23:59:59+00:00","payload":{"affected_area":null,"charge_text":"approximately $919,249","effective_date":"2024-01-31","event_type":"restructuring","headcount_text":"sixteen employees","item_codes_triggered":["2.05"]},"claim":"Streamex Corp. announced a restructuring with charges of approximately $919,249 (sixteen employees).","evidence_excerpt":"the Company estimates it will incur total aggregate costs of approximately $919,249, which consists of: payments for consulting services paid in equity in the estimated amount of $205,325; one-time departure fees and severance packages for employees in equity, based on factors including years of employment, in the estimated amount of $135,288; and retention bonuses paid in equity in the estimated amount of $578,636.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-004629","anchor_url":"https://secwatch.observer/filing/0001493152-24-004629#claim-800920b58914657d786a508dc1c2ddf5b1268912","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224004629/0001493152-24-004629-index.htm"},{"fact_type":"executive_change","fact_key":"c454a5f9d7","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-01T23:59:59+00:00","payload":{"action":"departing","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":null,"role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Gray Fleming departed as other_named_officer at Streamex Corp..","evidence_excerpt":"Mr. Sieckhaus and Mr. Fleming, effective as of the Effective Date, are departing from the Company.","confidence":0.8,"filing_url":"https://secwatch.observer/filing/0001493152-24-004629","anchor_url":"https://secwatch.observer/filing/0001493152-24-004629#claim-c454a5f9d7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224004629/0001493152-24-004629-index.htm"},{"fact_type":"executive_change","fact_key":"31665bda9f","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-02-01T23:59:59+00:00","payload":{"action":"departing","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":null,"role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"John Sieckhaus departed as other_named_officer at Streamex Corp..","evidence_excerpt":"Mr. Sieckhaus and Mr. Fleming, effective as of the Effective Date, are departing from the Company.","confidence":0.8,"filing_url":"https://secwatch.observer/filing/0001493152-24-004629","anchor_url":"https://secwatch.observer/filing/0001493152-24-004629#claim-31665bda9f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224004629/0001493152-24-004629-index.htm"},{"fact_type":"governance_change","fact_key":"e907946261805eebf24657f084300cf5ff648b72","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-01-31T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-02-01","item_codes_triggered":["5.03"],"summary_text":"Reverse stock split amendment to the Certificate of Incorporation at a ratio of 1-for-10"},"claim":"Streamex Corp.: Reverse stock split amendment to the Certificate of Incorporation at a ratio of 1-for-10 (effective 2024-02-01).","evidence_excerpt":"On January 31, 2024, the Company filed the Reverse Stock Split Amendment with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, effective as of 4:05 p.m. (New York time) on February 1, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-004491","anchor_url":"https://secwatch.observer/filing/0001493152-24-004491#claim-e907946261805eebf24657f084300cf5ff648b72","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224004491/0001493152-24-004491-index.htm"},{"fact_type":"material_agreement","fact_key":"f77ed575bf2c306f5d9ebea5615b5451326289b3","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2024-01-12T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited and institutional investors","effective_date":"2024-01-12","item_codes_triggered":["1.01"],"value_text":"gross proceeds from this offering were $1,040,000.11"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited and institutional investors valued at gross proceeds from this offering were $1,040,000.11 (effective 2024-01-12).","evidence_excerpt":"On January 12, 2024, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited and institutional investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 2,607,170 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and warrants (the “Warrants”) to purchase up to 1,303,585 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrants, the “Securities”), at a purchase price of $0.3989 per Share and a Warrant to purchase one-half of a Share.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-002266","anchor_url":"https://secwatch.observer/filing/0001493152-24-002266#claim-f77ed575bf2c306f5d9ebea5615b5451326289b3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315224002266/0001493152-24-002266-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a22cd25b4d3421a5e61290216edf33c7b190241e","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-12-28T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-27","outcome":"passed","proposal_text":"Approve issuance of shares underlying warrants in excess of 20% of outstanding common stock for purposes of complying with Nasdaq Listing Rule 5635(d).","proposal_type":"other","results":[{"broker_non_votes":"-","subject":null,"votes_abstain":"1,097,327","votes_against":"1,226,390","votes_for":"39,295,753","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Approve issuance of shares underlying warrants in excess of 20% of outstanding common stock for purposes of complying with Nasdaq Listing Rule 5635(d). at the 2023-12-27 meeting.","evidence_excerpt":"(1) A proposal to authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) underlying certain warrants issued by the Company pursuant to the terms of (i) that certain Securities Purchase Agreement, dated November 8, 2023, by and between the Company and an institutional investor and (ii) that certain Engagement Agreement, dated October 31, 2023, by and between the Company and H.C. Wainwright & Co., LLC, in an amount equal to or in excess of 20% of the Common Stock outstanding immediately prior to the issuance of such warrants (the “Issuance Proposal”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-046383","anchor_url":"https://secwatch.observer/filing/0001493152-23-046383#claim-a22cd25b4d3421a5e61290216edf33c7b190241e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223046383/0001493152-23-046383-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"8702dc1d30c5e1d9e002f792c600fe5cb906162f","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-12-22T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2024-06-17","deficiency_type":"market_value","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"$35,000,000","notice_date":"2023-12-22","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"minimum MVLS requirement pursuant to Nasdaq Listing Rule 5810(c)(3)(C)","reported_value":null,"rule_numbers":["5810(c)(3)(C)","5550(b)(3)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq deficiency notice notice regarding market value (rules 5810(c)(3)(C), 5550(b)(3)).","evidence_excerpt":"n which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(C). In\norder to regain compliance with Nasdaq’s minimum MVLS requirement, the Company’s MVLS must close at $35,000,000 or more for","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-045925","anchor_url":"https://secwatch.observer/filing/0001493152-23-045925#claim-8702dc1d30c5e1d9e002f792c600fe5cb906162f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223045925/0001493152-23-045925-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ad750552d6ddccd1b50e5a22264200d7972cd379","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-12-18T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-18","outcome":"passed","proposal_text":"Ratification of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"-","subject":null,"votes_abstain":"288,977","votes_against":"589,954","votes_for":"53,861,582","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Ratification of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-12-18 meeting.","evidence_excerpt":"Approval of the Auditor Ratification Proposal: For Against Abstain Broker Non-Votes 53,861,582 589,954 288,977 -","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-045282","anchor_url":"https://secwatch.observer/filing/0001493152-23-045282#claim-ad750552d6ddccd1b50e5a22264200d7972cd379","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223045282/0001493152-23-045282-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ab9aff763bf428a8ef56025c51a1715a614f5712","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-12-18T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-18","outcome":"passed","proposal_text":"Approval of amendment to 2023 Long-Term Incentive Plan to increase authorized shares by 3,500,000","proposal_type":"equity_plan","results":[{"broker_non_votes":"15,528,420","subject":null,"votes_abstain":"693,288","votes_against":"2,363,847","votes_for":"36,154,958","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Approval of amendment to 2023 Long-Term Incentive Plan to increase authorized shares by 3,500,000 at the 2023-12-18 meeting.","evidence_excerpt":"Approval of the Plan Amendment Proposal: For Against Abstain Broker Non-Votes 36,154,958 2,363,847 693,288 15,528,420","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-045282","anchor_url":"https://secwatch.observer/filing/0001493152-23-045282#claim-ab9aff763bf428a8ef56025c51a1715a614f5712","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223045282/0001493152-23-045282-index.htm"},{"fact_type":"shareholder_vote","fact_key":"c6125e14e5898775a112e3e436121e12e5bc3ad0","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-12-18T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-18","outcome":"passed","proposal_text":"Approval of reverse stock split at a ratio between 1-for-2 and 1-for-10","proposal_type":"reverse_split","results":[{"broker_non_votes":"-","subject":null,"votes_abstain":"234,121","votes_against":"6,606,612","votes_for":"47,899,780","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Approval of reverse stock split at a ratio between 1-for-2 and 1-for-10 at the 2023-12-18 meeting.","evidence_excerpt":"Approval of the Reverse Stock Split Proposal: For Against Abstain Broker Non-Votes 47,899,780 6,606,612 234,121 -","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-045282","anchor_url":"https://secwatch.observer/filing/0001493152-23-045282#claim-c6125e14e5898775a112e3e436121e12e5bc3ad0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223045282/0001493152-23-045282-index.htm"},{"fact_type":"shareholder_vote","fact_key":"11a2005bba14e4272afca1c82c22d585edf00621","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-12-18T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-18","outcome":"passed","proposal_text":"Election of seven directors to serve until 2024 annual meeting","proposal_type":"director_election","results":[{"broker_non_votes":"15,528,420","subject":"Kenneth L. Londoner","votes_abstain":null,"votes_against":null,"votes_for":"37,869,038","votes_withheld":"1,343,055"},{"broker_non_votes":"15,528,420","subject":"David Weild IV","votes_abstain":null,"votes_against":null,"votes_for":"38,069,486","votes_withheld":"1,142,607"},{"broker_non_votes":"15,528,420","subject":"Patrick J. Gallagher","votes_abstain":null,"votes_against":null,"votes_for":"37,801,725","votes_withheld":"1,410,368"},{"broker_non_votes":"15,528,420","subject":"Donald E. Foley","votes_abstain":null,"votes_against":null,"votes_for":"37,930,829","votes_withheld":"1,281,264"},{"broker_non_votes":"15,528,420","subject":"James J. Barry","votes_abstain":null,"votes_against":null,"votes_for":"38,074,136","votes_withheld":"1,137,957"},{"broker_non_votes":"15,528,420","subject":"Frederick D. Hrkac","votes_abstain":null,"votes_against":null,"votes_for":"38,189,433","votes_withheld":"1,022,660"},{"broker_non_votes":"15,528,420","subject":"James L. Klein","votes_abstain":null,"votes_against":null,"votes_for":"36,452,950","votes_withheld":"2,759,143"}]},"claim":"Streamex Corp. shareholders approved Election of seven directors to serve until 2024 annual meeting at the 2023-12-18 meeting.","evidence_excerpt":"Each of the following nominees for director received the number of votes set forth opposite his name, constituting in each case a plurality of the votes cast at the Annual Meeting for the election of such director to serve as a director on the Board until the 2024 Annual Meeting or until his successor has duly elected and qualified: Nominee Votes For Votes Withheld Broker Non-Votes Kenneth L. Londoner 37,869,038 1,343,055 15,528,420 David Weild IV 38,069,486 1,142,607 15,528,420 Patrick J. Gallagher 37,801,725 1,410,368 15,528,420 Donald E. Foley 37,930,829 1,281,264 15,528,420 James J. Barry 38,074,136 1,137,957 15,528,420 Frederick D. Hrkac 38,189,433 1,022,660 15,528,420 James L. Klein 36,452,950 2,759,143 15,528,420","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-045282","anchor_url":"https://secwatch.observer/filing/0001493152-23-045282#claim-11a2005bba14e4272afca1c82c22d585edf00621","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223045282/0001493152-23-045282-index.htm"},{"fact_type":"material_agreement","fact_key":"b99db2584f3443092dfc38aacd1c698f8df57636","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-11-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"institutional investor","effective_date":"2023-11-08","item_codes_triggered":["1.01"],"value_text":"6,996,922 shares of common stock at $0.3573 per share, Series A and Series B warrants, aggregate gro"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with institutional investor valued at 6,996,922 shares of common stock at $0.3573 per share, Series A and Series B warrants, aggregate gro (effective 2023-11-08).","evidence_excerpt":"On November 8, 2023, BioSig Technologies, Inc. (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”), (i) 6,996,922 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), (ii) Series A warrants (the “Series A Warrants”) to purchase up to 6,996,922 shares of Common Stock, and (iii) Series B Warrants (the “Series B Warrants”, and together with the Series A Warrants, the “Series Warrants”) to purchase up to 6,996,922 shares of Common Stock, at a purchase price of $0.3573 per Share and associated Series Warrants.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-040339","anchor_url":"https://secwatch.observer/filing/0001493152-23-040339#claim-b99db2584f3443092dfc38aacd1c698f8df57636","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/0001493152-23-040339-index.htm"},{"fact_type":"governance_change","fact_key":"6e66c476ff989839ced2a6fc0cc267e5a3ab3af4","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-11-08T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2023-11-02","item_codes_triggered":["5.03"],"summary_text":"Adopted Amendment No. 3 to the Amended and Restated Bylaws, changing voting requirements for director elections to a plurality of votes cast and for other matters to a majority of votes cast (excluding abstentions and broker non-votes)."},"claim":"Streamex Corp.: Adopted Amendment No. 3 to the Amended and Restated Bylaws, changing voting requirements for director elections to a plurality of votes cast and for other matters to a majority of votes cast (excluding abstentions and broker non-votes) (effective 2023-11-02).","evidence_excerpt":"On November 2, 2023, the board of directors of BioSig Technologies, Inc. (the “ Company ”) adopted Amendment No. 3 to the Amended and Restated Bylaws of the Company, as amended (the “ Third Amendment ”), which became effective as of the same date.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-039894","anchor_url":"https://secwatch.observer/filing/0001493152-23-039894#claim-6e66c476ff989839ced2a6fc0cc267e5a3ab3af4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223039894/0001493152-23-039894-index.htm"},{"fact_type":"material_agreement","fact_key":"ed5a2f1dbc814356c4e620132f228ab24f763896","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-11-02T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Sales Agreement","agreement_type":"atm_program","counterparty":"Ascendiant Capital Markets, LLC","effective_date":"2023-11-06","item_codes_triggered":["1.02"],"value_text":null},"claim":"Streamex Corp. terminated Sales Agreement with Ascendiant Capital Markets, LLC (effective 2023-11-06).","evidence_excerpt":"On November 1, 2023, the Company delivered written notice to the Agent to terminate the Sales Agreement, effective November 6, 2023, pursuant to Section 13(b) of the Sales Agreement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-001126","anchor_url":"https://secwatch.observer/filing/0001185185-23-001126#claim-ed5a2f1dbc814356c4e620132f228ab24f763896","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523001126/0001185185-23-001126-index.htm"},{"fact_type":"material_agreement","fact_key":"9d2134a37ac403df82095dfa13f513daeb41bd84","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-10-16T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited investors","effective_date":"2023-10-12","item_codes_triggered":["1.01"],"value_text":"$597,496.72"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $597,496.72 (effective 2023-10-12).","evidence_excerpt":"On October 12, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,129,996 shares (the “Shares”) of the Company’s common stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-001070","anchor_url":"https://secwatch.observer/filing/0001185185-23-001070#claim-9d2134a37ac403df82095dfa13f513daeb41bd84","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/0001185185-23-001070-index.htm"},{"fact_type":"material_agreement","fact_key":"7674982f375f627d3c055ed78ec23322d3c49eae","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-09-27T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited and institutional investors","effective_date":"2023-09-21","item_codes_triggered":["1.01"],"value_text":"$810,200.84"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited and institutional investors valued at $810,200.84 (effective 2023-09-21).","evidence_excerpt":"On September 21, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited and institutional investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,458,770 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.5554 per share, and warrants (the “Warrants”) to purchase up to 729,385 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrants, the “Securities”), at an exercise price of $0.4929 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $810,200.84 (the “September PIPE”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-001013","anchor_url":"https://secwatch.observer/filing/0001185185-23-001013#claim-7674982f375f627d3c055ed78ec23322d3c49eae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523001013/0001185185-23-001013-index.htm"},{"fact_type":"material_agreement","fact_key":"25fa706950687fb21bdd7fc10ca8952ebc38bb52","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-09-15T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Controlled Equity Offering SM Sales Agreement","agreement_type":"atm_program","counterparty":"Cantor Fitzgerald & Co.","effective_date":"2023-09-15","item_codes_triggered":["1.02"],"value_text":null},"claim":"Streamex Corp. terminated Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-09-15).","evidence_excerpt":"On September 15, 2023, the Company delivered written notice to Cantor to terminate the Cantor Agreement, effective September 15, 2023, pursuant to Section 12(b) of the Cantor Agreement.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000976","anchor_url":"https://secwatch.observer/filing/0001185185-23-000976#claim-25fa706950687fb21bdd7fc10ca8952ebc38bb52","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000976/0001185185-23-000976-index.htm"},{"fact_type":"material_agreement","fact_key":"9b1b6022febe8b6f1177e3f2a2dadbf990d05aa9","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-09-15T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Sales Agreement","agreement_type":"atm_program","counterparty":"Ascendiant Capital Markets, LLC","effective_date":"2023-09-15","item_codes_triggered":["1.01"],"value_text":null},"claim":"Streamex Corp. entered into Sales Agreement with Ascendiant Capital Markets, LLC (effective 2023-09-15).","evidence_excerpt":"On September 15, 2023, BioSig Technologies, Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Ascendiant Capital Markets, LLC, to act as the Company’s sales agent or principal (“Agent”), with respect to the issuance and sale of the Company’s shares of common stock, par value $0.001 per share (the “Shares”), from time to time in an at the market offering.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000976","anchor_url":"https://secwatch.observer/filing/0001185185-23-000976#claim-9b1b6022febe8b6f1177e3f2a2dadbf990d05aa9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000976/0001185185-23-000976-index.htm"},{"fact_type":"material_agreement","fact_key":"eff82bcaea69f53333abefec087a77bd44462548","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-09-12T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited investors","effective_date":"2023-09-12","item_codes_triggered":["1.01"],"value_text":"$549,999.29"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $549,999.29 (effective 2023-09-12).","evidence_excerpt":"On September 12, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 990,954 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.55502 per share, and warrants (the “Warrants”) to purchase up to 495,477 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrants, the “Securities”), at an exercise price of $0.49252 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $549,999.29","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000962","anchor_url":"https://secwatch.observer/filing/0001185185-23-000962#claim-eff82bcaea69f53333abefec087a77bd44462548","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000962/0001185185-23-000962-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"dee16f2c0bd1dc89e54717461359e649334ef61d","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-09-12T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2024-03-04","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"minimum bid price of $1.00 per share","notice_date":"2023-09-06","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(a)(2) and Nasdaq Listing Rule 5810(c)(3)(A)","reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"September 6, 2023, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days between July 25, 2023, to September 5, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, o","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000961","anchor_url":"https://secwatch.observer/filing/0001185185-23-000961#claim-dee16f2c0bd1dc89e54717461359e649334ef61d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000961/0001185185-23-000961-index.htm"},{"fact_type":"material_agreement","fact_key":"15a05f4003e88615e372959036463a3358fde9ee","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-08-18T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Controlled Equity Offering Sales Agreement","agreement_type":"atm_program","counterparty":"Cantor Fitzgerald & Co.","effective_date":"2023-08-18","item_codes_triggered":["1.01"],"value_text":null},"claim":"Streamex Corp. entered into Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-08-18).","evidence_excerpt":"On August 18, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co., to act as the Company’s sales agent or principal (“Agent”), with respect to the issuance and sale of the Company’s shares of common stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000873","anchor_url":"https://secwatch.observer/filing/0001185185-23-000873#claim-15a05f4003e88615e372959036463a3358fde9ee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000873/0001185185-23-000873-index.htm"},{"fact_type":"material_agreement","fact_key":"840badc6d86e9bc2c383a91a44e2fb3887cc112b","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-07-31T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"a certain accredited investor","effective_date":"2023-07-31","item_codes_triggered":["1.01"],"value_text":"$1,499,999.79"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with a certain accredited investor valued at $1,499,999.79 (effective 2023-07-31).","evidence_excerpt":"On July 31, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain accredited investor (the “Investor”), pursuant to which the Company sold to the Investor an aggregate of 1,467,624 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.02206 per share, and a warrant (the “Warrant”) to purchase up to 733,812 shares of Common Stock (the “Warrant Shares” and together with the Shares and the Warrant, the “Securities”), at an exercise price of $0.95956 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,499,999.79 (the “July PIPE”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000770","anchor_url":"https://secwatch.observer/filing/0001185185-23-000770#claim-840badc6d86e9bc2c383a91a44e2fb3887cc112b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000770/0001185185-23-000770-index.htm"},{"fact_type":"material_agreement","fact_key":"2ad7931db45f7f147c92580edfef0d54edfc3702","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-07-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2023-07-19","item_codes_triggered":["1.01"],"value_text":"$495,000"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $495,000 (effective 2023-07-19).","evidence_excerpt":"On July 19, 2023, BioSig AI Sciences, Inc., f/k/a NeuroClear Technologies Inc. (“BioSig AI”), a subsidiary of BioSig Technologies, Inc. (“BioSig”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which BioSig AI agreed to sell an aggregate of 495,000 shares (the “Shares”) of BioSig AI’s common stock, par value $0.001 per share (the “Common Stock”) for an aggregate purchase price of $495,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000751","anchor_url":"https://secwatch.observer/filing/0001185185-23-000751#claim-2ad7931db45f7f147c92580edfef0d54edfc3702","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000751/0001185185-23-000751-index.htm"},{"fact_type":"material_agreement","fact_key":"1af65ad41a0f6c19412951f2256afd23575ebe28","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-06-30T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited investors","effective_date":"2023-06-30","item_codes_triggered":["1.01"],"value_text":"$1,710,000"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,710,000 (effective 2023-06-30).","evidence_excerpt":"On June 30, 2023, BioSig AI Sciences, Inc., f/k/a NeuroClear Technologies Inc. (“BioSig AI”), a subsidiary of BioSig Technologies, Inc. (“BioSig”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which BioSig AI agreed to sell an aggregate of 1,710,000 shares (the “Shares”) of BioSig AI’s common stock, par value $0.001 per share (the “Common Stock”) for an aggregate purchase price of $1,710,000 (the “BioSig AI Private Placement”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000682","anchor_url":"https://secwatch.observer/filing/0001185185-23-000682#claim-1af65ad41a0f6c19412951f2256afd23575ebe28","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/0001185185-23-000682-index.htm"},{"fact_type":"material_agreement","fact_key":"7d355075cbec5c2e0c9710d75dd357d2ea6c2e19","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-05-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2023-05-16","item_codes_triggered":["1.01"],"value_text":"$2,500,747.51"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $2,500,747.51 (effective 2023-05-16).","evidence_excerpt":"On May 16, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,798,452 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.3905 per share, and warrants (the “Warrants”) to purchase up to 899,226 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.328 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $2,500,747.51 (the “May PIPE”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000571","anchor_url":"https://secwatch.observer/filing/0001185185-23-000571#claim-7d355075cbec5c2e0c9710d75dd357d2ea6c2e19","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000571/0001185185-23-000571-index.htm"},{"fact_type":"material_agreement","fact_key":"a2378debfb68d4903fdff24882675bd4229f95ce","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-04-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited and institutional investors","effective_date":"2023-04-18","item_codes_triggered":["1.01"],"value_text":"$945,001.40"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited and institutional investors valued at $945,001.40 (effective 2023-04-18).","evidence_excerpt":"On April 18, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited and institutional investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 792,454 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.1925 per share, and warrants (the “Warrants”) to purchase up to 396,227 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.13 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $945,001.40 (the “April PIPE”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000405","anchor_url":"https://secwatch.observer/filing/0001185185-23-000405#claim-a2378debfb68d4903fdff24882675bd4229f95ce","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000405/0001185185-23-000405-index.htm"},{"fact_type":"material_agreement","fact_key":"5dd8997acb212723f91b8c656aef3482f9ec9838","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-03-29T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited investors","effective_date":"2023-03-24","item_codes_triggered":["1.01"],"value_text":"$1,017,889.00"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,017,889.00 (effective 2023-03-24).","evidence_excerpt":"On March 24, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 935,130 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.0885 per share, and warrants (the “Warrants”) to purchase up to 467,565 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.026 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,017,889.00 (the “March PIPE”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000270","anchor_url":"https://secwatch.observer/filing/0001185185-23-000270#claim-5dd8997acb212723f91b8c656aef3482f9ec9838","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000270/0001185185-23-000270-index.htm"},{"fact_type":"material_agreement","fact_key":"68c5aa23349e6f0e105456c1e5d50e567b2b41f3","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-03-16T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2023-03-14","item_codes_triggered":["1.01"],"value_text":"aggregate consideration of $1,719,983.01"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at aggregate consideration of $1,719,983.01 (effective 2023-03-14).","evidence_excerpt":"On March 14, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,550,540 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.10928 per share, and warrants (the “Warrants”) to purchase up to 775,270 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.04678 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,719,983.01 (the “March PIPE”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000216","anchor_url":"https://secwatch.observer/filing/0001185185-23-000216#claim-68c5aa23349e6f0e105456c1e5d50e567b2b41f3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000216/0001185185-23-000216-index.htm"},{"fact_type":"material_agreement","fact_key":"ae7ceca101f75feb99c38a9a232b5294fd4ea425","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain accredited investors","effective_date":"2023-02-08","item_codes_triggered":["1.01"],"value_text":"aggregate consideration of $409,994.75"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at aggregate consideration of $409,994.75 (effective 2023-02-08).","evidence_excerpt":"On February 8, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 382,308 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.07242 per share, and warrants (the “Warrants”) to purchase up to 191,154 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.00992 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $409,994.75.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000120","anchor_url":"https://secwatch.observer/filing/0001185185-23-000120#claim-ae7ceca101f75feb99c38a9a232b5294fd4ea425","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000120/0001185185-23-000120-index.htm"},{"fact_type":"shareholder_vote","fact_key":"8c34fbc437ceb853e63d1f0e915940c73a32a842","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-02-07","outcome":"passed","proposal_text":"A proposal to approve the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan","proposal_type":"equity_plan","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"421,207","votes_against":"1,615,076","votes_for":"24,741,946","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved A proposal to approve the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan at the 2023-02-07 meeting.","evidence_excerpt":"The number of votes cast for and against and the number of abstentions and broker non-votes with respect to the matter voted upon are set forth below: (1) A proposal to approve the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan: For Against Abstain Broker Non-Votes 24,741,946 1,615,076 421,207 -","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000112","anchor_url":"https://secwatch.observer/filing/0001185185-23-000112#claim-8c34fbc437ceb853e63d1f0e915940c73a32a842","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000112/0001185185-23-000112-index.htm"},{"fact_type":"material_agreement","fact_key":"772e027bbd0545b057f5d34f8276ba882addf502","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-08T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2023-02-03","item_codes_triggered":["1.01"],"value_text":"$1,366,994.90"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,366,994.90 (effective 2023-02-03).","evidence_excerpt":"On February 3, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,591,750 shares (the “Shares”) of the Company’s common stock","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000102","anchor_url":"https://secwatch.observer/filing/0001185185-23-000102#claim-772e027bbd0545b057f5d34f8276ba882addf502","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000102/0001185185-23-000102-index.htm"},{"fact_type":"executive_change","fact_key":"8aebdc95c2","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-02-06","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Steve Buhaly was appointed as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 2, 2023, the Board appointed Mr. Steve Buhaly as the Chief Financial Officer of the Company, whose employment will commence on February 6, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000088","anchor_url":"https://secwatch.observer/filing/0001185185-23-000088#claim-8aebdc95c2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000088/0001185185-23-000088-index.htm"},{"fact_type":"executive_change","fact_key":"0fe13195de","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-07T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Steve Buhaly","successor_named":true},"claim":"Steve Chaussy was terminated as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 2, 2023, the BioSig Technologies, Inc. (the “ Company ”) entered into a General Release and Severance Agreement (the “ Release Agreement ”) with Steve Chaussy, Chief Financial Officer of the Company, pursuant to which Mr. Chaussy’s employment with the Company will terminate upon the earlier of April 28, 2023, or the date of an earlier termination","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000088","anchor_url":"https://secwatch.observer/filing/0001185185-23-000088#claim-0fe13195de","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000088/0001185185-23-000088-index.htm"},{"fact_type":"executive_change","fact_key":"d04b5fe5f1","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-02-06","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Steve Buhaly was appointed as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 2, 2023, the Board appointed Mr. Steve Buhaly as the Chief Financial Officer of the Company, whose employment will commence on February 6, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000100","anchor_url":"https://secwatch.observer/filing/0001185185-23-000100#claim-d04b5fe5f1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000100/0001185185-23-000100-index.htm"},{"fact_type":"executive_change","fact_key":"a47e940b4d","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-02-07T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":null,"interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Steve Buhaly","successor_named":true},"claim":"Steve Chaussy was terminated as Chief Financial Officer at Streamex Corp..","evidence_excerpt":"On February 2, 2023, the BioSig Technologies, Inc. (the “ Company ”) entered into a General Release and Severance Agreement (the “ Release Agreement ”) with Steve Chaussy, Chief Financial Officer of the Company, pursuant to which Mr. Chaussy’s employment with the Company will terminate at such point when his services are no longer required","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-23-000100","anchor_url":"https://secwatch.observer/filing/0001185185-23-000100#claim-a47e940b4d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000100/0001185185-23-000100-index.htm"},{"fact_type":"material_agreement","fact_key":"3a21011063a7164789b3177ad36b297ae32f15fb","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-01-26T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2023-01-25","item_codes_triggered":["1.01"],"value_text":"aggregate consideration of $159,997.87"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at aggregate consideration of $159,997.87 (effective 2023-01-25).","evidence_excerpt":"On January 25, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 196,872 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.8127 per share, and warrants (the “Warrants”) to purchase up to 98,436 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.7502 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $159,997.87.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000073","anchor_url":"https://secwatch.observer/filing/0001185185-23-000073#claim-3a21011063a7164789b3177ad36b297ae32f15fb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000073/0001185185-23-000073-index.htm"},{"fact_type":"material_agreement","fact_key":"5f7f0a1227bfb03c87481dc8568315458f0e60c3","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-01-24T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"an accredited investor (the \"Investor\")","effective_date":"2023-01-23","item_codes_triggered":["1.01"],"value_text":"$1,299,998.75"},"claim":"Streamex Corp. entered into Purchase Agreement with an accredited investor (the \"Investor\") valued at $1,299,998.75 (effective 2023-01-23).","evidence_excerpt":"On January 23, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”), pursuant to which the Company sold to the Investor 1,665,384 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.7806 per share, and a warrant (the “Warrant”) to purchase up to 832,692 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrant, the “Securities”), at an exercise price of $0.7181 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for consideration of $1,299,998.75.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000062","anchor_url":"https://secwatch.observer/filing/0001185185-23-000062#claim-5f7f0a1227bfb03c87481dc8568315458f0e60c3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000062/0001185185-23-000062-index.htm"},{"fact_type":"material_agreement","fact_key":"910a1a8b088671130b666e8308b7510ce1996455","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2023-01-17T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2023-01-10","item_codes_triggered":["1.01"],"value_text":"$1,254,884.28"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,254,884.28 (effective 2023-01-10).","evidence_excerpt":"On January 10, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 2,178,316 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.57608 per share, and warrants (the “Warrants”) to purchase up to 1,089,158 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.51358 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,254,884.28.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-23-000034","anchor_url":"https://secwatch.observer/filing/0001185185-23-000034#claim-910a1a8b088671130b666e8308b7510ce1996455","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000034/0001185185-23-000034-index.htm"},{"fact_type":"material_agreement","fact_key":"130aae7376a6a14531d0a06959c17eacab8332c1","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-12-28T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"certain institutional and accredited investors","effective_date":"2022-12-21","item_codes_triggered":["1.01"],"value_text":"$1,098,091.79"},"claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,098,091.79 (effective 2022-12-21).","evidence_excerpt":"On December 21, 2022, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 2,161,598 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.508 per share, and warrants (the “Warrants”) to purchase up to 1,080,799 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $0.4455 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $1,098,091.79 (the “December PIPE”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001454","anchor_url":"https://secwatch.observer/filing/0001185185-22-001454#claim-130aae7376a6a14531d0a06959c17eacab8332c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001454/0001185185-22-001454-index.htm"},{"fact_type":"governance_change","fact_key":"c22c74949729397c6da853dff7f50a65a1f50665","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-12-28T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2022-12-27","item_codes_triggered":["5.03"],"summary_text":"Lowered the quorum threshold at stockholder meetings to one-third of voting power"},"claim":"Streamex Corp.: Lowered the quorum threshold at stockholder meetings to one-third of voting power (effective 2022-12-27).","evidence_excerpt":"The Second Amendment amends and restates Article II, Section 2.6 of the Company’s Amended and Restated Bylaws in its entirety to lower the threshold required to achieve a quorum at all meetings of the Company’s stockholders to one-third of the voting power of the stock issued, outstanding and entitled to vote, present in person or represented by proxy.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001453","anchor_url":"https://secwatch.observer/filing/0001185185-22-001453#claim-c22c74949729397c6da853dff7f50a65a1f50665","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001453/0001185185-22-001453-index.htm"},{"fact_type":"shareholder_vote","fact_key":"aa5ba1299e60d0f5b50a4ecff0a82f1df58cf886","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-20","outcome":"passed","proposal_text":"Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the 2022 fiscal year","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"67,772","votes_against":"279,296","votes_for":"31,860,583","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the 2022 fiscal year at the 2022-12-20 meeting.","evidence_excerpt":"(4) Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the 2022 fiscal year: For Against Abstain Broker Non-Votes 31,860,583 279,296 67,772 -","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001444","anchor_url":"https://secwatch.observer/filing/0001185185-22-001444#claim-aa5ba1299e60d0f5b50a4ecff0a82f1df58cf886","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001444/0001185185-22-001444-index.htm"},{"fact_type":"shareholder_vote","fact_key":"93a640a09bad4333fbe142beccd9d9b8656c64fa","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-20","outcome":"passed","proposal_text":"Advisory vote on the compensation of the Company's named executive officers as described in the 2022 Proxy Statement","proposal_type":"say_on_pay","results":[{"broker_non_votes":"10,622,958","subject":null,"votes_abstain":"171,937","votes_against":"2,925,924","votes_for":"18,486,832","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Advisory vote on the compensation of the Company's named executive officers as described in the 2022 Proxy Statement at the 2022-12-20 meeting.","evidence_excerpt":"(3) Approval of an advisory vote on the compensation of the Company's named executive officers as described in the 2022 Proxy Statement: For Against Abstain Broker Non-Votes 18,486,832 2,925,924 171,937 10,622,958","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001444","anchor_url":"https://secwatch.observer/filing/0001185185-22-001444#claim-93a640a09bad4333fbe142beccd9d9b8656c64fa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001444/0001185185-22-001444-index.htm"},{"fact_type":"shareholder_vote","fact_key":"52d5ad21c35145475459163478524dcc914adf67","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-20","outcome":"passed","proposal_text":"Approval of an amendment to the Amended and Restated Certificate of Incorporation to effect a reverse stock split of all outstanding shares of common stock at a ratio in the range of 1-for-2 to 1-for-10","proposal_type":"reverse_split","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"124,269","votes_against":"3,721,643","votes_for":"28,361,739","votes_withheld":null}]},"claim":"Streamex Corp. shareholders approved Approval of an amendment to the Amended and Restated Certificate of Incorporation to effect a reverse stock split of all outstanding shares of common stock at a ratio in the range of 1-for-2 to 1-for-10 at the 2022-12-20 meeting.","evidence_excerpt":"(2) Approval of the Reverse Stock Split Proposal: For Against Abstain Broker Non-Votes 28,361,739 3,721,643 124,269 -","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001444","anchor_url":"https://secwatch.observer/filing/0001185185-22-001444#claim-52d5ad21c35145475459163478524dcc914adf67","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001444/0001185185-22-001444-index.htm"},{"fact_type":"shareholder_vote","fact_key":"653d4fd99763b920f56ad511b73be4ab91f00eb5","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-12-21T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2022-12-20","outcome":"passed","proposal_text":"Election of seven directors to serve until the Company's 2023 annual meeting of stockholders or until their successors have been duly elected and qualified","proposal_type":"director_election","results":[{"broker_non_votes":"10,622,958","subject":"Kenneth L. Londoner","votes_abstain":null,"votes_against":null,"votes_for":"19,582,352","votes_withheld":"2,002,341"},{"broker_non_votes":"10,622,958","subject":"James J. Barry","votes_abstain":null,"votes_against":null,"votes_for":"19,294,323","votes_withheld":"2,290,370"},{"broker_non_votes":"10,622,958","subject":"David Weild IV","votes_abstain":null,"votes_against":null,"votes_for":"19,691,976","votes_withheld":"1,892,717"},{"broker_non_votes":"10,622,958","subject":"Patrick J. Gallagher","votes_abstain":null,"votes_against":null,"votes_for":"18,798,724","votes_withheld":"2,785,969"},{"broker_non_votes":"10,622,958","subject":"Donald E. Foley","votes_abstain":null,"votes_against":null,"votes_for":"18,956,636","votes_withheld":"2,628,057"},{"broker_non_votes":"10,622,958","subject":"Frederick D. Hrkac","votes_abstain":null,"votes_against":null,"votes_for":"19,274,781","votes_withheld":"2,309,912"},{"broker_non_votes":"10,622,958","subject":"James L. Klein","votes_abstain":null,"votes_against":null,"votes_for":"19,903,747","votes_withheld":"1,680,946"}]},"claim":"Streamex Corp. shareholders approved Election of seven directors to serve until the Company's 2023 annual meeting of stockholders or until their successors have been duly elected and qualified at the 2022-12-20 meeting.","evidence_excerpt":"Each of the following nominees for director received the number of votes set forth opposite his name, constituting in each case a plurality of the votes cast at the Annual Meeting for the election of such director to serve for a term of one year or until his successor is duly elected and qualified: Nominee Votes For Votes Withheld Broker Non-Votes Kenneth L. Londoner 19,582,352 2,002,341 10,622,958 James J. Barry 19,294,323 2,290,370 10,622,958 David Weild IV 19,691,976 1,892,717 10,622,958 Patrick J. Gallagher 18,798,724 2,785,969 10,622,958 Donald E. Foley 18,956,636 2,628,057 10,622,958 Frederick D. Hrkac 19,274,781 2,309,912 10,622,958 James L. Klein 19,903,747 1,680,946 10,622,958","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001444","anchor_url":"https://secwatch.observer/filing/0001185185-22-001444#claim-653d4fd99763b920f56ad511b73be4ab91f00eb5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001444/0001185185-22-001444-index.htm"},{"fact_type":"material_agreement","fact_key":"21cd138734c36db0c874d17d6add27337662ae3b","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-11-30T23:59:59+00:00","payload":{"action":"termination","agreement_name":"ATM Sales Agreement","agreement_type":"atm_program","counterparty":"Virtu Americas LLC","effective_date":"2022-12-01","item_codes_triggered":["1.02"],"value_text":"up to $10,000,000"},"claim":"Streamex Corp. terminated ATM Sales Agreement with Virtu Americas LLC valued at up to $10,000,000 (effective 2022-12-01).","evidence_excerpt":"On November 30, 2022, the Company delivered written notice to the Agent to terminate the Sales Agreement, effective December 1, 2022 pursuant to Section 13(b) of the Sales Agreement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001375","anchor_url":"https://secwatch.observer/filing/0001185185-22-001375#claim-21cd138734c36db0c874d17d6add27337662ae3b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001375/0001185185-22-001375-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"521d9a489ab5fae3c01cd6065f17c84acdf292a9","cik":1530766,"ticker":"STEX","company_name":"Streamex Corp.","filed_at":"2022-11-29T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"$2,500,000","notice_date":"2022-11-22","notice_type":"deficiency_notice","plan_due_date":"2023-01-06","raw_rule_text":"Nasdaq Listing Rule 5550(b)(1)","reported_value":"$1,834,000","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Streamex Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"November 22, 2022, BioSig Technologies, Inc. (the “Company”) received a letter (the “Letter”) from The Nasdaq Stock Market (“Nasdaq”) informing the Company that the Company failed to maintain a minimum of $2,500,000 in stockholders’ equity required for continued listing (the “Stockholders’ Equity Requirement”) on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) based upon the reported stockholders’ equity of $1,834,000 in the Company’s quarterly report on Form 10-Q for the period ended September 30, 2022 and that as of November 22, 2022, the Company did not meet the alternative c","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-22-001371","anchor_url":"https://secwatch.observer/filing/0001185185-22-001371#claim-521d9a489ab5fae3c01cd6065f17c84acdf292a9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001371/0001185185-22-001371-index.htm"}]}